Filana Therapeutics (FLNA) Other financing activities (2010 - 2025)
Filana Therapeutics (FLNA) posted quarterly Other financing activities of $90000.0 for Q1 2025, down 99.6% year-over-year from $22.3 million in Q1 2024, and down 99.91% quarter-over-quarter from $101.3 million in Q2 2024.
Filana Therapeutics (FLNA) Other financing activities (2010 - 2025) Analysis & Trends
Filana Therapeutics' Other financing activities history runs 10 years deep, the most recent figure standing at $90000.0 for Q1 2025.
- In Q1 2025, Other financing activities fell 99.6% year-over-year to $90000.0; the TTM figure through Dec 2025 stood at $90000.0 (down 99.93% YoY), while the FY2025 annual figure was $90000.0, down 99.93% from the prior year.
- Other financing activities for Q1 2025 stood at $90000.0, down from $101.3 million in the prior quarter.
- The five-year high for Other financing activities was $101.3 million in Q2 2024, with the low at $9000.0 in Q4 2022.
- The 5-year median for Other financing activities is $578000.0 (2021), against an average of $12.7 million.
- The sharpest annual moves came in 2024 and 2025: Other financing activities surged 34743.75% in 2024, then sank 99.6% in 2025.
- Filana Therapeutics' Other financing activities stood at $692000.0 in 2021, then tumbled by 98.7% to $9000.0 in 2022, then soared by 12600.0% to $1.1 million in 2023, then surged by 8758.44% to $101.3 million in 2024, then tumbled by 99.91% to $90000.0 in 2025.
- Business Quant data shows FLNA's Other financing activities at $90000.0 in Q1 2025, $101.3 million in Q2 2024, and $22.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - |
| 10 | Filana Therapeutics | 46.30 Mn | 46.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Jun 30, 2024 | 101.25 Mn |
| Jun 30, 2024 | 101.25 Mn |
| Mar 31, 2024 | 22.30 Mn |
| Mar 31, 2024 | 22.30 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 464,000.00 |
| Sep 30, 2023 | 464,000.00 |
| Jun 30, 2023 | 889,000.00 |
| Jun 30, 2023 | 889,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Mar 31, 2022 | 211,000.00 |
| Mar 31, 2022 | 211,000.00 |
| Mar 31, 2021 | 692,000.00 |
| Mar 31, 2021 | 692,000.00 |